Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46445 | 18611188 | Aliment Pharmacol Ther | Adipokines and cytokines in non-alcoholic fatty liver disease. | 2008 | Details |
| A46452 | 18542010 | Curr Opin Clin Nutr Metab Care | Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. | 2008 | Details |
| A46454 | 18523032 | J Endocrinol | Antagonism of central melanin-concentrating hormone 1 receptor alleviates steatohepatitis in mice. | 2008 | Details |
| A46456 | 18510615 | Am J Gastroenterol | In search of an ideal biomarker for nonalcoholic fatty liver disease. | 2008 | Details |
| A46460 | 18460922 | Curr Opin Lipidol | Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. | 2008 | Details |
| A46461 | 18458848 | J Gastroenterol | High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis. | 2008 | Details |
| A46469 | 18413180 | J Diabetes Complications | Clinical resolution of glycogenic hepatopathy following improved glycemic control. | 2008 | Details |
| A46470 | 18408460 | Curr Opin Gastroenterol | Recent advances in nonalcholic fatty liver disease. | 2008 | Details |
| A46474 | 18393289 | Hepatology | Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. | 2008 | Details |
| A46480 | 18370731 | Metab Syndr Relat Disord | Non-alcoholic Fatty liver disease and malignancy as complications of insulin resistance. | 2005 | Details |
| A46482 | 18367000 | Curr Diab Rep | Fatty liver, insulin resistance, and dyslipidemia. | 2008 | Details |
| A46483 | 18366995 | Curr Diab Rep | Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. | 2008 | Details |
| A46486 | 18355813 | Gastroenterology | Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. | 2008 | Details |
| A46489 | 18344805 | Medicine (Baltimore) | Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. | 2008 | Details |
| A46492 | 18277910 | J Clin Gastroenterol | Therapy for nonalcoholic fatty liver disease. | 2008 | Details |
| A46493 | 18277391 | Obesity (Silver Spring) | Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. | 2008 | Details |
| A46495 | 18227502 | Diabetes Care | Metabolic complications of childhood obesity: identifying and mitigating the risk. | 2008 | Details |
| A46496 | 18268061 | Gut | Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease. | 2008 | Details |
| A46499 | 18245813 | Am J Pathol | Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. | 2008 | Details |
| A46500 | 18235842 | Mol Med | Inflammatory mechanisms in the regulation of insulin resistance. | 2008 | Details |
| A46508 | 18187076 | Am J Med | Carotid artery intima-media thickness in nonalcoholic fatty liver disease. | 2008 | Details |
| A46510 | 30743783 | Expert Rev Endocrinol Metab | Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein. | 2008 | Details |
| A46512 | 18161723 | Hepatology | Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle. | 2008 | Details |
| A46514 | 18082476 | Dig Liver Dis | Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. | 2007 | Details |
| A46515 | 18078871 | Metabolism | Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet. | 2008 | Details |
| A46516 | 18068003 | Arch Med Res | Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. | 2007 | Details |
| A46517 | 18054848 | Dig Liver Dis | Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. | 2007 | Details |
| A46521 | 18008034 | J Gastroenterol | The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. | 2007 | Details |
| A46522 | 17979073 | Semin Liver Dis | Endoplasmic reticulum stress and liver injury. | 2007 | Details |
| A46524 | 17965308 | Diabetes Care | Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children: response to Nobili et al. | 2007 | Details |
| A46526 | 17959863 | Diabetes Care | Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. | 2007 | Details |
| A46530 | 17904449 | Am J Med | Impact of diabetes on the severity of liver disease. | 2007 | Details |
| A46536 | 17720354 | Am J Med | Abdominal adiposity and cardiometabolic risk: do we have all the answers? | 2007 | Details |
| A46547 | 17691941 | Curr Med Chem | Hepatobiliary diseases and insulin resistance. | 2007 | Details |
| A46561 | 17578885 | Am J Physiol Endocrinol Metab | Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. | 2007 | Details |
| A46566 | 17547681 | Clin Endocrinol (Oxf) | A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. | 2007 | Details |
| A46568 | 17536073 | Diabetes Care | Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. | 2007 | Details |
| A46569 | 17526824 | Diabetes Care | Nonalcoholic fatty liver disease and insulin resistance in youth. | 2007 | Details |
| A46574 | 17512312 | Metabolism | Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. | 2007 | Details |
| A46575 | 17498512 | Gastroenterology | Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. | 2007 | Details |
| A46576 | 17498510 | Gastroenterology | Obesity, inflammation, and insulin resistance. | 2007 | Details |
| A46586 | 17431009 | Endocrinology | Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. | 2007 | Details |
| A46590 | 17410454 | Dig Dis Sci | The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. | 2007 | Details |
| A46591 | 17408630 | Gastroenterology | The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. | 2007 | Details |
| A46594 | 17396083 | Gastroenterol Clin Biol | [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications]. | 2007 | Details |
| A46603 | 17354303 | N Engl J Med | Pioglitazone in nonalcoholic steatohepatitis. | 2007 | Details |
| A46607 | 17324347 | Curr Infect Dis Rep | Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment. | 2007 | Details |
| A46608 | 17318260 | J Clin Invest | Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. | 2007 | Details |
| A46609 | 17306008 | Acta Paediatr | MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. | 2007 | Details |
| A46614 | 17278239 | World J Gastroenterol | Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. | 2007 | Details |
| A46617 | 17268250 | Curr Opin Gastroenterol | Fatty liver and the metabolic syndrome. | 2007 | Details |
| A46618 | 17267845 | Obstet Gynecol | Management of obesity in pregnancy. | 2007 | Details |
| A46622 | 17244464 | Zhonghua Gan Zang Bing Za Zhi | [Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance]. | 2007 | Details |
| A46626 | 17164118 | Clin Liver Dis | Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection. | 2006 | Details |
| A46628 | 17145635 | Am J Clin Pathol | Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease. | 2007 | Details |
| A46629 | 17136797 | Mayo Clin Health Lett | Nonalcoholic fatty liver disease. A growing problem. | 2006 | Details |
| A46630 | 17114290 | Proc Natl Acad Sci U S A | Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. | 2006 | Details |
| A46631 | 17099371 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. | 2006 | Details |
| A46632 | 17099068 | FASEB J | Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. | 2006 | Details |
| A46640 | 16968796 | J Clin Endocrinol Metab | Serum resistin and hepatic fat content in nondiabetic individuals. | 2006 | Details |
| A46641 | 16952562 | Gastroenterology | Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. | 2006 | Details |
| A46644 | 16938178 | Zhonghua Gan Zang Bing Za Zhi | [Association between tumor necrosis factor-alpha gene polymorphism and insulin resistance in nonalcoholic fatty liver disease]. | 2006 | Details |
| A46645 | 16932311 | Nat Clin Pract Endocrinol Metab | Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. | 2006 | Details |
| A46647 | 16912555 | Curr Opin Clin Nutr Metab Care | Assessment of metabolic profile in a clinical setting. | 2006 | Details |
| A46648 | 16912127 | J Clin Endocrinol Metab | Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. | 2006 | Details |
| A46656 | 16825939 | J Clin Gastroenterol | Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia. | 2006 | Details |
| A46657 | 16825675 | Am J Clin Nutr | Nonalcoholic fatty liver, nonalcoholic steatohepatitis, ectopic fat, and the glycemic index. | 2006 | Details |
| A46658 | 16799888 | J Gastroenterol | Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. | 2006 | Details |
| A46659 | 16780999 | J Hepatol | Bromocriptine reduces steatosis in obese rodent models. | 2006 | Details |
| A46660 | 16774486 | Expert Opin Drug Saf | Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139. | 2006 | Details |
| A46661 | 16771968 | Am J Gastroenterol | Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A46663 | 16770927 | Am Fam Physician | Nonalcoholic fatty liver disease. | 2006 | Details |
| A46664 | 16767302 | Arq Bras Endocrinol Metabol | [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome]. | 2006 | Details |
| A46665 | 16762001 | Liver Int | Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. | 2006 | Details |
| A46669 | 16729327 | Hepatology | Impact of obesity on treatment of chronic hepatitis C. | 2006 | Details |
| A46671 | 16708768 | Altern Ther Health Med | The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease. | 2006 | Details |
| A46674 | 16698763 | Gut | A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations. | 2006 | Details |
| A46678 | 16618425 | Gastroenterology | Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. | 2006 | Details |
| A46680 | 16584696 | Gastroenterol Hepatol | [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. | 2006 | Details |
| A46690 | 16510031 | Curr Gastroenterol Rep | New treatments for nonalcoholic fatty liver disease. | 2006 | Details |
| A46692 | 16489319 | Panminerva Med | Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. | 2005 | Details |
| A46693 | 16478772 | Am J Physiol Endocrinol Metab | Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. | 2006 | Details |
| A46696 | 16460473 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: the unfolding monster? | 2006 | Details |
| A46698 | 16444867 | Vasc Med | Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. | 2005 | Details |
| A46708 | 16311087 | Metabolism | Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations. | 2005 | Details |
| A46714 | 16269465 | Endocrinology | Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. | 2005 | Details |
| A46715 | 16265231 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease. | 2005 | Details |
| A46721 | 16226915 | Hepatol Res | Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. | 2005 | Details |
| A46726 | 16175602 | Hepatology | Steatohepatitis induced by intragastric overfeeding in mice. | 2005 | Details |
| A46729 | 16161764 | J Nutr Sci Vitaminol (Tokyo) | Influence of royal jelly on mouse hepatic gene expression and safety assessment with a DNA microarray. | 2005 | Details |
| A46730 | 16160540 | Curr Opin Pediatr | Nonalcoholic fatty liver disease in the pediatric population: a review. | 2005 | Details |
| A46738 | 16011474 | Annu Rev Nutr | Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. | 2005 | Details |
| A46741 | 15990637 | J Pediatr Gastroenterol Nutr | Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. | 2005 | Details |
| A46742 | 15990591 | Curr Opin Lipidol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2005 | Details |
| A46743 | 15989845 | Med Clin (Barc) | [Medical management of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46744 | 15989823 | Gastroenterol Hepatol | [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver]. | 2005 | Details |
| A46751 | 15920084 | Diabetes Care | Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease. | 2005 | Details |
| A46752 | 15913829 | J Hepatol | Signalling links in the liver: knitting SOCS with fat and inflammation. | 2005 | Details |
| A46755 | 15882516 | Med Clin (Barc) | [Pathogenesis of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46756 | 15855597 | Diabetes Care | Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. | 2005 | Details |